South Indian Children's Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study.
South Indian Children's Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study.
复制标题
DOI:
10.1093/cid/ciab792
复制
发表时间:
2022-01-20
期刊:
影响因子:
--
通讯作者:
Santhanam S
中科院分区:
文献类型:
--
作者:
John HB;Arumugam A;Priya M;Murugesan N;Rajendraprasad N;Rebekah G;Paul P;Chandna J;Lawn JE;Santhanam S
This study is part of a multicountry matched-cohort study designed to estimate the risk of long-term neurodevelopmental impairment (NDI) of children exposed to invasive group B Streptococcus (iGBS). The specific objective of this paper is to compare NDI across domains of iGBS survivors with a matched non iGBS group in our population. Survivors of iGBS in a South Indian hospital were identified and recruited between January 2020 and April 2021. Cases were compared with age- and gender-matched non iGBS children. Participants were assessed using Bayley Scales of Infant and Toddler Development–3rd edition (BSID-III), Wechsler Preschool and Primary Scale of Intelligence–4th edition (WPPSI-IV), Wechsler Intelligence Scale for Children–5th edition (WISC-V), Child Behavior Checklist (CBCL), and Bruininks-Oseretsky Test of Motor Proficiency, 2nd edition (BOT-2), depending on age. Our cohort comprised 35 GBS-exposed and 65 matched non iGBS children, aged 1–14 years. The iGBS-exposed group had 17 (48.6%) children with impairment in ≥1 domain compared to 25 (38%) in the non iGBS group (unadjusted OR, 1.51; 95% CI, .65–3.46), 9 (26%) children with “multi-domain impairment” compared to 10 (15.4%) in the non iGBS group (unadjusted OR, 1.90; 95% CI, .69–5.24), and 1 (2.9%) child with moderate to severe impairment compared to 3 (4.6%) in the non iGBS group (unadjusted OR, .60; 95% CI, .06–6.07). In the iGBS group, more children had motor impairments compared with the non iGBS group (unadjusted OR, 10.7; 95% CI, 1.19–95.69; P = .034). Children with iGBS seem at higher risk of developing motor impairments compared with a non iGBS group.
登录
查看更多内容
影响因子:
2
作者:
Oommen, Samuel P.;Santhanam, Sridhar;Yadav, Bijesh
通讯作者:
Yadav, Bijesh
影响因子:
--
作者:
Paul, Proma;Procter, Simon R;Lawn, Joy E
通讯作者:
Lawn, Joy E
影响因子:
1.7
作者:
Ruan-Iu, Linda;Pendergast, Laura L.;Murray-Kolb, Laura E.
通讯作者:
Murray-Kolb, Laura E.
DOI:
10.1093/cid/cix656
发表时间:
2017-11-06
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Madrid L;Seale AC;Kohli-Lynch M;Edmond KM;Lawn JE;Heath PT;Madhi SA;Baker CJ;Bartlett L;Cutland C;Gravett MG;Ip M;Le Doare K;Rubens CE;Saha SK;Sobanjo-Ter Meulen A;Vekemans J;Schrag S;Infant GBS Disease Investigator Group
通讯作者:
Infant GBS Disease Investigator Group
影响因子:
168.9
作者:
Mwaniki, Michael K.;Atieno, Maurine;Lawn, Joy E.;Newton, Charles R. J. C.
通讯作者:
Newton, Charles R. J. C.